34 opportunities found using the current filters, sorted by opening date
UKRI and RCN have signed a Money Follows Cooperation agreement to enable collaborative applications between researchers in the UK and Norway. UKRI funding will be provided for co-investigators from Norway in successful applications.
Conditions will differ depending on the funding opportunity.
UKRI and FNR have signed a memorandum of understanding to enable and support applications between researchers in the UK and Luxembourg. UKRI will fund the UK component and FNR will fund the Luxembourg component of the application.
Conditions will differ depending on the funding opportunity.
UK Research and Innovation (UKRI) and FAPESP’s lead agency agreement allows UKRI to assess joint applications from eligible UK and Brazil-based researchers from the state of São Paulo on behalf of both organisations.
UKRI and FAPESP will co-fund applications submitted to responsive mode funding opportunities via selected funding opportunities.
Apply for funding to research myalgic encephalomyelitis/chronic fatigue syndrome, also known as ME/CFS.
Apply for funding to research motor neurone disease (MND).
You can get funding through any:
You should apply through the existing funding opportunity that is most relevant to your science area and career stage.
Apply for funding for the application of artificial intelligence (AI), engineering biology, and quantum technologies in biomedical research and development.
You must be based at a UK research organisation eligible for MRC funding.
Apply for funding to investigate the causes, progression and treatment of human disease. Your application must include an intervention in humans.
You must be based at an eligible research organisation. Researchers transitioning to independence may be eligible to apply as a ‘new investigator’.
Apply for MRC Centre of Research Excellence (MRC CoRE) funding to tackle complex and interdisciplinary health challenges.
You must be based at a UK research organisation eligible for MRC funding.
Apply for funding to lead a cluster in a coordinated network for novel human in vitro models of complex disease.
You must:
We anticipate funding up to five clusters for four years with a total fund of £15 million.
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions.
You must be employed at a research organisation eligible for MRC funding.
